Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

RSS icon
Thumbnail

Extubating heart surgery patients in OR safe with lower costs

Extubating low- and moderate-risk patients in the operating room (OR) after cardiac surgeries can lower costs and shorten lengths of stay at no added risk, according to a study published in the December issue of the Journal of Thoracic and Cardiovascular Surgery.

For physicians, training area impacts early spending in practice

Physician spending habits can be learned, but they also can change, a study found. In the first years of practice, residency spending patterns had the greatest impact on expenditures per patient, according to a study published in the Dec. 10 issue of JAMA.

Thumbnail

Cost analysis may support ICU transfers for intracranial bleeding

When it comes to long-term cost in transferring patients to specialized neurological intensive care units following an intracerebral hemorrhage, patient outcomes play a significant role.

Medicare maintains Kcentra’s add-on pay status

The Centers for Medicare & Medicaid Services (CMS) will continue to pay an additional amount for a reversal agent to warfarin for in-hospital treatments through Sept. 15, 2015.

Thumbnail

Exercise beats stenting, medical care for PAD costs

Proponents of supervised exercise as a treatment for peripheral artery disease (PAD) can flex their muscles a bit more with policy makers and payers after a cost-effectiveness analysis showed the approach to be a good value.

Payment rate on S-ICD set for increase

The Medicare outpatient payment rate for implanting certain implantable defibrillator devices will increase by 23 percent on Jan. 1, 2015, thanks to a change in its designation.

Real-world data presented at the American Heart Association (AHA) Scientific Sessions underscore hospitalization and outpatient cost-savings for XARELTO compared to standard of care

New data presented today at the American Heart Association (AHA) 2014 Scientific Sessions showed once-daily XARELTO® (rivaroxaban) is associated with significantly fewer hospitalization days and outpatient visits compared to warfarin in patients with non-valvular atrial fibrillation (NVAF). Corresponding hospitalization and outpatient healthcare costs were also significantly lower for XARELTO® compared to warfarin in NVAF patients, according to longitudinal, real-world findings from this observational study.

AHA.14: Readmission penalties hit inner-city hospitals hardest

Medicare penalties on 30-day readmissions for MI, heart failure and pneumonia disproportionately ding inner-city hospitals with disadvantaged patients, findings presented Nov. 17 at the American Heart Association scientific session in Chicago showed. “It is affecting those safety-net hospitals,” said lead researcher Arshad A. Javed, MD. 

Displaying 1385 - 1392 of 1706

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.